Filtrera efter Last updated date SelectEfterFöreFrom - To Date Slutdatum Denna vecka Den här månaden Förra veckan Förra månaden Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationMedicine shortagesResearch and developmentBiosimilarsSMEAntimicrobial resistanceCorporateGovernanceBrexitQuality of medicinesGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationScientific adviceMedical devicesMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate useCareersMedication errorPRIMEParallel distributionProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety information Patient safety Lämna detta fält tomt Filter Resultat (3827) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Lämna detta fält tomt ICMRA and WHO map out flexibilities used by regulators to respond to the COVID-19 pandemic 3 december 2021NewsHumanCOVID-19MedicinesVaccines Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 29 November - 2 December 2021 3 december 2021NewsHumanCOVID-19PharmacovigilanceReferralsVaccines EMA starts rolling review of Valneva’s COVID-19 vaccine (VLA2001) 2 december 2021NewsHumanCOVID-19Vaccines Increase in manufacturing capacity for COVID-19 vaccine from AstraZeneca 1 december 2021NewsHumanCOVID-19Vaccines Comirnaty COVID-19 vaccine: EMA recommends approval for children aged 5 to 11 25 november 2021NewsHumanCOVID-19Vaccines A vision for use of real-world evidence in EU medicines regulation 24 november 2021NewsHumanCorporate EMA receives application for marketing authorisation for Lagevrio (molnupiravir) for treating patients with COVID 19 23 november 2021NewsHumanCOVID-19Medicines 2011-2020: More than 40% decrease in sales of antimicrobials for use in animals 23 november 2021NewsVeterinaryAntimicrobial resistance EMA evaluating data on booster dose of COVID-19 Vaccine Janssen 22 november 2021NewsHumanCOVID-19Vaccines EMA issues advice on use of Lagevrio (molnupiravir) for the treatment of COVID-19 19 november 2021NewsHumanCOVID-19Medicines 1 … 53 54 55 56 57 Page 57 of 383 58 59 60 61 … 383
ICMRA and WHO map out flexibilities used by regulators to respond to the COVID-19 pandemic 3 december 2021NewsHumanCOVID-19MedicinesVaccines
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 29 November - 2 December 2021 3 december 2021NewsHumanCOVID-19PharmacovigilanceReferralsVaccines
EMA starts rolling review of Valneva’s COVID-19 vaccine (VLA2001) 2 december 2021NewsHumanCOVID-19Vaccines
Increase in manufacturing capacity for COVID-19 vaccine from AstraZeneca 1 december 2021NewsHumanCOVID-19Vaccines
Comirnaty COVID-19 vaccine: EMA recommends approval for children aged 5 to 11 25 november 2021NewsHumanCOVID-19Vaccines
A vision for use of real-world evidence in EU medicines regulation 24 november 2021NewsHumanCorporate
EMA receives application for marketing authorisation for Lagevrio (molnupiravir) for treating patients with COVID 19 23 november 2021NewsHumanCOVID-19Medicines
2011-2020: More than 40% decrease in sales of antimicrobials for use in animals 23 november 2021NewsVeterinaryAntimicrobial resistance
EMA evaluating data on booster dose of COVID-19 Vaccine Janssen 22 november 2021NewsHumanCOVID-19Vaccines
EMA issues advice on use of Lagevrio (molnupiravir) for the treatment of COVID-19 19 november 2021NewsHumanCOVID-19Medicines